Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of eighth biannual meeting (September 2015)

被引:51
|
作者
不详
机构
[1] Global Malaria Programme,
[2] World Health Organization,undefined
来源
MALARIA JOURNAL | 2016年 / 15卷
关键词
WHO; Malaria; Policy making; Mosquito control; Drug resistance; Surveillance; Elimination; Plasmodium falciparum; Plasmodium vivax;
D O I
10.1186/s12936-016-1169-x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The Malaria Policy Advisory Committee (MPAC) to the World Health Organization held its eighth meeting in Geneva, Switzerland from 16 to 18 September 2015. This article provides a summary of the discussions, conclusions and meeting recommendations. Meeting sessions included: recommendations from the Evidence Review Group (ERG) on mass drug administration; recommendations from the ERG on malaria in pregnancy; recommendations on when to scale back vector control; feedback on the Plasmodium vivax technical brief and the recommendation for G6PD testing before treatment; updates on artemisinin and artemisinin-based combination therapy resistance and the Greater Mekong Subregion elimination strategy; an update from the working group on malaria terminology; and updates on malaria elimination in the World Health Organization European region, the ERG on malaria elimination, and World Health Organization reform to support innovation, efficiency and quality in vector control tools. Policy statements, position statements, and guidelines that arise from the MPAC meeting conclusions and recommendations will be issued formally and disseminated to World Health Organization Member States by the World Health Organization Global Malaria Programme.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Chile's National Advisory Committee on Immunization (CAVEI): Evidence-based recommendations for public policy decision-making on vaccines and immunization
    Dabanch, Jeannette
    Gonzalez, Cecilia
    Cerda, Jaime
    Acevedo, Johanna
    Calvo, Mario
    Diaz, Eduardo
    Endeiza, Maria
    Inostroza, Jaime
    Rodriguez, Jaime
    Saldana, Adiela
    Santillana, Solange
    El Omeiri, Nathalie
    Bastias, Magdalena
    VACCINE, 2019, 37 (32) : 4646 - 4650
  • [42] Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021
    Dooling, Kathleen
    Gargano, Julia W.
    Moulia, Danielle
    Wallace, Megan
    Rosenblum, Hannah G.
    Blain, Amy E.
    Hadler, Stephen C.
    Plumb, Ian D.
    Moline, Heidi
    Gerstein, Jack
    Collins, Jennifer P.
    Godfrey, Monica
    Campos-Outcalt, Doug
    Morgan, Rebecca L.
    Brooks, Oliver
    Talbot, H. Keipp
    Lee, Grace M.
    Daley, Matthew F.
    Oliver, Sara E.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (38): : 1344 - 1348
  • [43] Report on the meeting of the Second Ad Hoc Committee on the TB epidemic: Recommendations to Stop TB Partners, Montreux, Switzerland, 18-19 September 2003
    Billo, N
    Bloom, A
    Broekmans, J
    Dayrit, M
    Dumelle, F
    Elzinga, G
    England, S
    Espinal, M
    Kutwa, A
    Maher, D
    Narayanan, PR
    Omaswa, F
    Raviglione, M
    Robb, A
    Shah, K
    Tapia, R
    Vink, K
    Weil, D
    Young, D
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2004, 8 (11) : 1279 - 1284
  • [44] Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) (vol 64, pg 944, 2015)
    Kobayashi, Miwako
    Bennett, Nancy M.
    Gierke, Ryan
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2015, 64 (42): : 1204 - 1204
  • [45] Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses - Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015
    Petersen, Brett W.
    Harms, Tiara J.
    Reynolds, Mary G.
    Harrison, Lee H.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2016, 65 (10): : 257 - 262
  • [46] Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7-9th Sep 2015
    Giersing, Birgitte K.
    Modjarrad, Kayvon
    Kaslow, David C.
    Moorthy, Vasee S.
    VACCINE, 2016, 34 (26) : 2865 - 2869
  • [47] Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥ 10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015
    Folaranmi, Temitope
    Rubin, Lorry
    Martin, Stacey W.
    Patel, Manisha
    MacNeil, Jessica R.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2015, 64 (22): : 608 - 612
  • [48] Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2023
    Regan, Joanna J.
    Moulia, Danielle L.
    Link-Gelles, Ruth
    Godfrey, Monica
    Mak, Josephine
    Najdowski, Morgan
    Rosenblum, Hannah G.
    Shah, Melisa M.
    Twentyman, Evelyn
    Meyer, Sarah
    Peacock, Georgina
    Thornburg, Natalie
    Havers, Fiona P.
    Saydah, Sharon
    Brooks, Oliver
    Talbot, H. Keipp
    Lee, Grace M.
    Bell, Beth P.
    Mahon, Barbara E.
    Daley, Matthew F.
    Fleming-Dutra, Katherine E.
    Wallace, Megan
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2023, 72 (42): : 1140 - 1146
  • [49] Report from the World Health Organization ' s immunization and vaccines related implementation research advisory committee (IVIR-AC) meeting, Geneva, 11-13 September 2023
    Lambach, Philipp
    Orenstein, Walt
    Silal, Sheetal
    Sbarra, Alyssa N.
    Koh, Mitsuki
    Aggarwal, Rakesh
    Farooqui, Habib Hasan
    Flasche, Stefan
    Hogan, Alexandra
    Kim, Sun -Young
    Leask, Julie
    Luz, Paula M.
    Lyimo, Dafrossa C.
    Moss, William J.
    Pitzer, Virginia E.
    Wang, Xian -Yi
    Wu, Joseph
    VACCINE, 2024, 42 (07) : 1424 - 1434